National Institutes of Health: Renal Insufficiency trials

The registry lists 34 Renal Insufficiency studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 7Phase 2 7Phase 3 3No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CAR-T Cell Therapy for Desensitization in Kidney TransplantationRecruitingNCT06056102Phase 1
• Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal FunctionCompletedNCT03896750Phase 1Results posted
• Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant RejectionCompletedNCT00801632Phase 2Results posted
• Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation RecipientsCompletedNCT00240994Phase 2Results posted
• Sirolimus and Thymoglobulin to Prevent Kidney Transplant RejectionCompletedNCT00006178Phase 2Results posted
• Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)CompletedNCT00001959Phase 2Results posted
• African American Study of Kidney Disease and HypertensionCompletedNCT04364139Phase 3
• Clopidogrel Prevention of Early Arteriovenous (AV) Fistula ThrombosisCompletedNCT03289520Phase 3
• A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 StudyCompletedNCT01974999
• Study of the Complications Associated With Certain Stem Cell TransplantsCompletedNCT01919099
• Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver DysfunctionTerminatedNCT01907802Phase 1
• Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionActive, not recruitingNCT01366144Phase 1
• Live Kidney Donor Study -Renal Function StudyCompletedNCT01158742
• Role of Donor Genetics and Recipient Genetics in Kidney Transplant OutcomesCompletedNCT01143532
• Immune Development in Pediatric Transplantation (IMPACT)CompletedNCT00951353
• Safety of Immunosuppression Minimization in Children and Adolescents After Kidney TransplantationCompletedNCT00768729Phase 1
• Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant SurvivalCompletedNCT00531921
• Noninvasive Methods to Monitor Graft Survival in Kidney Transplant PatientsCompletedNCT00308802
• Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%TerminatedNCT00090194Phase 2
• Patient-Provider Trust Among Individuals With End-Stage Kidney DiseaseCompletedNCT00075036
• Aggrenox Prevention of Access StenosisCompletedNCT00067119Phase 3
• Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney FailureCompletedNCT00062621Phase 1
• Cardiac and Renal Disease Study (CARDS)CompletedNCT00049907
• Isoflavones and Acute-phase Response in Chronic Renal FailureCompletedNCT00029796Phase 2
• Search for New Methods to Detect Acute Renal FailureTerminatedNCT00026702
• Parathyroid Hormone Levels in Relation to the Phosphorus Content of MealsCompletedNCT00018135Not applicable
• Comparison of Daily Nocturnal Hemodialysis With Daily HemodialysisStatus unknownNCT00012441Not applicable
• Kidney Transplant for HIV-Infected Patients in Renal FailureCompletedNCT00009009Phase 2
• Prospective Controlled Study of Posttransplant DiabetesStatus unknownNCT00006331
• Risk Factors for CV Disease in a Dialysis CohortCompletedNCT00006297
• Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)CompletedNCT00005536
• Fifteen Year Follow-up of 5,500 Black and 5,500 Other HypertensivesCompletedNCT00005417
• Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell TransplantCompletedNCT00001859
• A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal DysfunctionCompletedNCT00001298Phase 1